Literature DB >> 29679573

circRNA expression analysis in lung adenocarcinoma: comparison of paired fresh frozen and formalin-fixed paraffin-embedded specimens.

Fan Zhang1, Xing Zhao1, Hongyan Dong2, Jianzhen Xu3.   

Abstract

Circular RNA (circRNAs) is a novel class of endogenous non-coding RNAs which is widely involved in carcinogenesis. Archived formalin-fixed paraffin-embedded (FFPE) specimens represent valuable resources for cancer research. Currently there is a lack of systematic analysis on the feasibility of circRNAs expression analysis using FFPE samples. Here, we reported the first comparison study of circRNA expression from paired fresh frozen and FFPE specimens of lung adenocarcinoma. circRNAs expression of paired lung adenocarcinoma and adjacent normal samples, starting from either fresh frozen or FFPE materials, were analyzed via a high-throughput circRNA microarray. Hierarchical clustering was performed on samples. qRT-PCR was used to confirm the differentially expressed circRNAs. The circRNA regulation networks were built by bioinformatics tools for several candidate circRNAs. Our results demonstrated that there was a good correlation in circRNAs expression analysis utilizing fresh frozen or FFPE tissues. Tumors and adjacent normal tissues can be clustered correctly by the differentially expressed circRNAs in fresh frozen or FFPE groups. Furthermore, three differentially expressed circRNAs, hsa_circRNA_100421, hsa_circRNA_104329 and hsa_circRNA_101969 were verified by qRT-PCR assay. Bioinformatics analysis was also applied to predict the circRNA-miRNA-protein coding gene interaction network for each of above circRNAs. To the best of our knowledge, this is the first report demonstrating that the circRNAs microarray analysis, starting from FFPE specimens, is comparable with that based on fresh frozen samples. Therefore FFPE specimen represents a good substitute for fresh frozen tissue, especially when fresh frozen specimen is limited.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FFPE specimens; Lung adenocarcinoma; circRNA microarray

Mesh:

Substances:

Year:  2018        PMID: 29679573     DOI: 10.1016/j.bbrc.2018.04.145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  circRNA Hsa_circ_0020850 Silence Represses the Development of Lung Adenocarcinoma via Regulating miR-195-5p/IRS2 Axis.

Authors:  Tuye Xin; Shuangshuang Li; Ying Zhang; Xiayizha Kamali; Hui Liu; Tengfei Jia
Journal:  Cancer Manag Res       Date:  2020-10-28       Impact factor: 3.989

Review 2.  Circular RNAs: Biogenesis, Mechanism, and Function in Human Cancers.

Authors:  Xing Zhao; Yujie Cai; Jianzhen Xu
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

Review 3.  Current and Future Roles of Circular RNAs in Normal and Pathological Endometrium.

Authors:  Jiajie Tu; Huan Yang; Yu Chen; Yu Chen; He Chen; Zhe Li; Lei Li; Yuanyuan Zhang; Xiaochun Chen; Zhiying Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

4.  Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens.

Authors:  Carlos Pedraz-Valdunciel; Stavros Giannoukakos; Nicolas Potie; Ana Giménez-Capitán; Chung-Ying Huang; Michael Hackenberg; Alberto Fernandez-Hilario; Jill Bracht; Martyna Filipska; Erika Aldeguer; Sonia Rodríguez; Trever G Bivona; Sarah Warren; Cristina Aguado; Masaoki Ito; Andrés Aguilar-Hernández; Miguel Angel Molina-Vila; Rafael Rosell
Journal:  Mol Oncol       Date:  2022-02-10       Impact factor: 7.449

5.  Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality.

Authors:  Hannah Rochow; Antonia Franz; Monika Jung; Sabine Weickmann; Bernhard Ralla; Ergin Kilic; Carsten Stephan; Annika Fendler; Klaus Jung
Journal:  Theranostics       Date:  2020-07-23       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.